Ms Eva Sarma

KANDO id: 34882

Bio

Prior to 3i, was a member of the Merrill Lynch Healthcare Team, working on transactions including the £150 million London initial public offering of generic pharmaceutical company, Hikma Pharmaceuticals, and the Swiss listing of the biotech company, Speedel. Prior to Merrill Lynch, was part of the PricewaterhouseCoopers Healthcare Team where she focused on M&A assignments in the OTC and healthcare services sectors. Recent deals include the acquisition of Agent Provocateur, the market-leading designer, producer and retailer of luxury lingerie, and the acquisition of Euro-Druckservice, the leading web-offset printer in the Czech Republic, Poland and Hungary. Member of the board of directors of Agent Provocateur. Masters degree in Engineering from Cambridge University.

Career


3i Group PLC

Major, long established, quoted private equity investor
Buyouts

Education